These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32647098)

  • 1. Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulation.
    Prieto E; Cardiel MJ; Vispe E; Idoipe M; Garcia-Martin E; Fraile JM; Polo V; Mayoral JA; Pablo LE; Rodrigo MJ
    Biomed Mater; 2020 Nov; 15(6):065021. PubMed ID: 32647098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser-induced intrachoroidal dexamethasone drug delivery system to posterior eye segment.
    Murata M; Sanbe A; Lee JW; Nishigori H
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8317-24. PubMed ID: 24265021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone distribution characteristic following controllable continuous sub-tenon drug delivery in rabbit.
    Huang X; Peng M; Yang Y; Duan Y; Li K; Liu S; Ye C; Lin D
    Drug Deliv; 2017 Nov; 24(1):818-824. PubMed ID: 28509581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.
    Chang-Lin JE; Attar M; Acheampong AA; Robinson MR; Whitcup SM; Kuppermann BD; Welty D
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):80-6. PubMed ID: 20702826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.
    Hou H; Wang C; Nan K; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):557-66. PubMed ID: 26882530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety study of intravitreal and suprachoroidal Laponite clay in rabbit eyes.
    Prieto E; Vispe E; De Martino A; Idoipe M; Rodrigo MJ; Garcia-Martin E; Fraile JM; Polo-Llorens V; Mayoral JA
    Graefes Arch Clin Exp Ophthalmol; 2018 Mar; 256(3):535-546. PubMed ID: 29353344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes.
    Kadam RS; Williams J; Tyagi P; Edelhauser HF; Kompella UB
    Mol Vis; 2013; 19():1198-210. PubMed ID: 23734089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
    Chastain JE; Sanders ME; Curtis MA; Chemuturi NV; Gadd ME; Kapin MA; Markwardt KL; Dahlin DC
    Exp Eye Res; 2016 Apr; 145():58-67. PubMed ID: 26474497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the release profile and pharmacokinetics of intact and fragmented dexamethasone intravitreal implants in rabbit eyes.
    Bhagat R; Zhang J; Farooq S; Li XY
    J Ocul Pharmacol Ther; 2014 Dec; 30(10):854-8. PubMed ID: 25411827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tolerance study of intravitreal injection of dexamethasone-loaded nanoparticles in rabbits.
    Zhang L; Li Y; Zhang C; Wang Y; Song C
    Int J Nanomedicine; 2009; 4():175-83. PubMed ID: 19774116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes.
    Chang-Lin JE; Burke JA; Peng Q; Lin T; Orilla WC; Ghosn CR; Zhang KM; Kuppermann BD; Robinson MR; Whitcup SM; Welty DF
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4605-9. PubMed ID: 21421864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J; Lan B; Li X; Sun S; Lu P; Cheng L
    J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Drug Distribution and Safety of a Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in Rabbit.
    Papangkorn K; Higuchi JW; Brar B; Higuchi WI
    J Ocul Pharmacol Ther; 2018 May; 34(4):325-334. PubMed ID: 29432054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.
    Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Ogura Y
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):238-44. PubMed ID: 14691179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dosage form on the intravitreal pharmacokinetics of diclofenac.
    Durairaj C; Kim SJ; Edelhauser HF; Shah JC; Kompella UB
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4887-97. PubMed ID: 19516015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.
    Wang C; Hou H; Nan K; Sailor MJ; Freeman WR; Cheng L
    Exp Eye Res; 2014 Dec; 129():74-82. PubMed ID: 25446320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical sustained drug delivery to the retina with a drug-eluting contact lens.
    Ross AE; Bengani LC; Tulsan R; Maidana DE; Salvador-Culla B; Kobashi H; Kolovou PE; Zhai H; Taghizadeh K; Kuang L; Mehta M; Vavvas DG; Kohane DS; Ciolino JB
    Biomaterials; 2019 Oct; 217():119285. PubMed ID: 31299627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular pharmacokinetics profile of different indomethacin topical formulations.
    Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
    Loftsson T; Hreinsdóttir D; Stefánsson E
    J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.